{"id":20879,"date":"2018-05-16T15:31:00","date_gmt":"2018-05-16T15:31:00","guid":{"rendered":"https:\/\/www.he-arc.ch\/projets-recherche\/drugsens\/"},"modified":"2022-02-03T12:38:33","modified_gmt":"2022-02-03T11:38:33","slug":"drugsens","status":"publish","type":"he-arc_project","link":"https:\/\/www.he-arc.ch\/en\/projets-recherche\/drugsens\/","title":{"rendered":"DrugSens"},"content":{"rendered":"\n

Context and challenges<\/h2>\n\n\n\n

In hospitals during cancer chemotherapies, patients are subjects to administration of very high doses of the therapeutic substance during several days. Ideally, drug doses should be continuously adjusted resulting in medicament blood concentrations being kept within a therapeutic range. This requires regular blood tests (typically every 15 to 30 minutes).<\/p>\n\n\n\n

Objectives<\/h2>\n\n\n\n